Teva to Host Conference Call to Discuss Fourth Quarter and Full Year 2021 Financial Results and 2022 Financial Guidance at 8 a.m. ET on February 9, 2022
Teva Reports Second Quarter 2021 Financial Results | Business Wire
Teva, Kåre Schultz | FiercePharma
2nd Annual NASDAQ TASE Israeli Investor Conference Dan Suesskind, CFO Teva Pharmaceutical Industries Ltd. November 27, ppt download
TEVA Stock Up on Q4 Earnings Beat, Sales Miss Estimates | Nasdaq